FDA.reportPublic FDA data

AndroGel 1.62 % (20.25MG / 1.25GM) Transdermal Gel

RxCUI
1597121
RxNorm name
AndroGel 1.62 % (20.25MG / 1.25GM) Transdermal Gel
Display name
AndroGel 1.62 % (20.25MG / 1.25GM) Transdermal Gel
Full name
AndroGel 1.62 % (20.25MG / 1.25GM) Transdermal Gel
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f4e8d29b-8707-4d47-e053-2a95a90aeceeAndroGel 1.62 % (20.25MG / 1.25GM) Transdermal Gel [PSN] · 1250 MG testosterone 0.0162 MG/MG Topical Gel [Androgel] [SBD] · 1250 MG Androgel 0.0162 MG/MG Topical Gel [SY] · Androgel 1.62 % Transdermal Gel, 1.25 GM [SY]4130These highlights do not include all the information needed to use ANDROGEL 1.62% safely and effectively. See full prescribing information for ANDROGEL 1.62%. ANDROGEL ® (testosterone gel) 1.62% for topical use CIII Initial U.S. Approval: 195320251022